News & Articles

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

Partnership will strengthen UK cell and gene therapy manufacturing pathway

In this SelectScience interview, explore key challenges, analytical solutions and future directions in cell line development

Researchers are uncovering previously unknown sources of PFAS using robotic sample preparation and high-resolution mass spectrometry

This newest and most compact member of the Biomek i-Series family is ideal for accelerating entry-level to medium-throughput workflows

Stanford Cancer Center South Bay streamlines chemistry test delivery with CLSI AUTO15, boosting lab efficiency and patient care

Dr. Becky Upton, President of Pistoia Alliance, looks to the future of lab innovation in this guest editorial

New reagent kit enables perfused, microvascularized 3D tumor models for organ-on-chip studies

Part two of the Quality Data, Informed Action webinar series explores how informatics and essential quality indicators can enhance patient safety

Expanding maintenance and support for LHS customers, and strengthening sales reach and application expertise

Collaboration aims to equip users with complete NGS solution from sample to answer

DynamiQ™ integrates diverse breadth of multi-omic measures with paired real-world data from serial samples to enable deep analysis of patient journeys, disease drivers, and drug response

Our one day social media takeover on Linkedin

Dr. Manu De Rycker, a Principal Investigator at the University of Dundee, has been named as the newest winner of the WH Pierce Global Impact in Microbiology Prize

Take the survey and submit a guest editorial

Tell us which new products have had the biggest impact on your lab work for a chance to win one of four $100 Amazon.com Gift Cards

Latest Spectrus applications offer deeper integrations, improvement to low code/no code automation, expansion of data import/export, and enhanced analytical data processing and interpretation, and Percepta delivers improved prediction accuracy for several models

Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy

Enables ultra-low variant detection across a range of key measurable residual disease targets in acute myeloid leukaemia, including very large FLT3-ITDs

Developed by a physician-led team, the panel arrives pre-plated in a 96-well format and features a modular, breakaway design to reduce waste and streamline lab workflows

Discover how CancerTools.org is empowering the distribution of researcher-created tools across the globe